Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
147
天
PDGF-BB and bFGF repress Kai1 in pericytes through Src–DNMT-associated promoter methylation and lysosomal trafficking
作者
Cheong-Whan Chae; Taehun Yoon; Yoo-Wook Kwon; Hyo-Soo Kim展开收起
作者单位
1. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; 2. Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea; 3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea展开收起
249
天
B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells
作者
Zechuan Peng; Jiasheng Zhong; Shengsong Fu; Yunhe Zhao; Jie Liu; Fei Wu; Zetao Chen; Tianwei Wang; Yiquan Ke; Taoliang Chen展开收起
作者单位
1. Neurosurgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 2. Department of Neuro-oncological Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 3. National Key Clinical Specialty, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 4. Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases, Ministry of Education, Southern Medical University, Guangzhou, China; 5. Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Southern Medical University, Guangzhou, China; 6. Zhujiang Hospital Institute for Brain Science and Intelligence, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 7. Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China展开收起
433
天
RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway
作者
Dan Wang; Xing Niu; Jingqi Tian; Ruibin Liu; Yuxuan Song; Dingye Zhang; Junze Dai; Shenglong Li; Xudong Zhu展开收起
作者单位
1. Department of Breast and Thyroid Surgery, Dalian Economic and Technological Development Zone Hospital, Dalian, China; 2. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; 3. China Medical University, Shenyang, China; 4. Department of Hepatopancreatobiliary Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China; 5. Liaoning Provincial Key Laboratory of Precision Medicine for Malignant Tumors, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China; 6. Department of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China; 7. State Key Laboratory of Oncology in South China, Guangzhou, China; 8. Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, China展开收起
179
天
Disassembly of PKA holoenzyme organization marks prostate cancer progression
作者
Tal Benjamin-Zukerman; Ran Katz; Gilat Shimon; Meir Solomon; Mirjam M. Nordling-David; Puspashree Sahoo; Basem Hijazi; Ali Safadi; Ronit Ilouz展开收起
作者单位
1. The Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel; 2. Department of Urology, Ziv Medical Center, affiliated with Azrieli Faculty of Medicine in the Galilee, Safed, Israel; 3. The Leslie & Susan Goldschmied (Gonda) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel展开收起
313
天
Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1–dependent palmitic acid metabolic reprogramming in colorectal cancer
作者
Yuqin Long; Xue Li; Yunxi Zhu; Yang Shen; Xiaotian Zhou; Ziqin Wei; Yin Yue; Jie Zhang; Changhong Miao展开收起
作者单位
1. Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China; 2. Shanghai Key Laboratory of Perioperative Stress and Protection, and Shanghai Clinical Research Center for Anesthesiology, Shanghai, China; 3. Department of Anesthesiology, Shanghai Medical College, Fudan University, Shanghai, China展开收起
379
天
Stabilization of LTBP2 by SIRT1 promotes EMT and chemosensitivity in cardia gastric adenocarcinoma through TGF-β signaling
作者
Wang Zhenxiang; Tian Tongguan; Chen Ying; Zhang Yan; Qian Meng; Sun Huihui; Xu Yanping; Xu Shuchang展开收起
作者单位
1. Department of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; 2. Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China展开收起
FAQ
ONCOGENE审稿要多久?
截至2026-11-18,CrushSCI 收录了 ONCOGENE 的 25 篇完整审稿记录。最快一篇从收稿到录用用了 92 天(tRNA-derived small RNAs in tumor microenvironment remodeling: From mechanistic insights to therapeutic perspectives,2026-04-21 收稿,2026-07-22 录用),最慢一篇用了 433 天;平均 239.0 天,中位数 238 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
